Malignant testicular unclassified sex cord stromal tumor: a case report

BACKGROUND: Most testicular tumors are germ cell tumors; sex cord stromal tumors are infrequent, accounting for only 3–5% of testicular tumors.

Unclassified sex cord stromal tumors are extremely rare.

Generally, 10% of sex cord stromal tumors are malignant.

We report a case of malignant unclassified sex cord stromal tumor with retroperitoneal lymph node metastasis at first visit and a corresponding literature review.

CASE PRESENTATION: A 72-year-old Japanese man visited our department primarily for indolent right scrotum enlargement in September 2020.

Blood biochemistry examination, urinalysis, and tumor markers (alpha-fetoprotein, human chorionic gonadotropin, and lactate dehydrogenase) showed no abnormal findings.

Contrast-enhanced computed tomography showed enlarged para-aortic lymph node (18 × 16 and 10 × 10(2) mm); a 50 × 45(2) mm mass with uneven contents was found in the right testicle.

The patient underwent inguinal orchiectomy in September 2020.

As per immunohistochemistry, the tumor cells were diffusely positive for SF-1 and Ki-67, partially positive for inhibin, and negative for CAM5.2, CK7, CK20, C-KIT, CD30, LCA, GATA-3, TTF-1, and PAX8.

Calretinin was expressed in approximately 5% of tumor cells; thus, sex cord/gonadal stroma components were considered to be involved.

The final pathological diagnosis was unclassified malignant sex cord stromal tumor.

The patient was diagnosed with pT1, N1, M0, S0, and tumor–node–metastasis stage IIA disease.

The patient received postoperative chemotherapy with four courses of etoposide and cisplatin therapy from November 2020.

Post-chemotherapeutic computed tomography showed new metastatic lesions including lung, liver, pancreas, and para-aortic lymphadenopathy, which increased in size.

Disease progression was observed.

Cancer genome research was performed using the OncoGuide National Cancer Center oncopanel system; however, no gene mutation for which the drug could be expected to be effective was found.

The patient opted for best supportive care at a nearby hospital and died from cancer progression in January 2022.

CONCLUSION: We encountered a case of malignant testicular unclassified sex cord stromal tumor pathologically diagnosed as testicular tumor with retroperitoneal lymph node metastasis in a patient who underwent inguinal orchiectomy.

Future data collection is necessary to establish multimodality therapy for malignant testicular unclassified sex cord stromal tumor.